StockTipsArenaBeta

BUY Anupam Rasayan India Limited — ICICI Securities

BUYAnupam Rasayan India Limited
Anupam Rasayan India share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)19 Aug 2026via NDTV Profit

Entry₹1,220Inferred
Target₹1,345
Total upside +10.25%
Stop lossNot given
CMP₹1,108.41h ago
Active-9.15%+21.35%upside left 10 mo left
Follow ICICI Securities for new calls(67% target hit, 1026 closed calls)Get alertsWatch ANURAS for new buy/sell callsGet alertsSee 211 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:37 pm IST
10 supporting11 neutral0 opposing
Supports the BUY call (10)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·21 Oct · yesterday

Anupam Rasayan India Limited has completed the acquisition of Bliss GVS Pharma as part of its strategy to build an integrated global pharmaceutical platform.

NSE · Press Release·28 Sept · 3w ago

(opens in new tab)

The company has completed the acquisition of Bliss GVS Pharma as part of its strategic expansion.

BSE · Company Update·28 Sept · 3w ago

(opens in new tab)
Neutral / worth noting (11)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Anupam Rasayan India

All analyst calls on Anupam Rasayan India

More from ICICI Securities

Every call and its outcome